Global Diabetic Footwear Market Size to worth USD 17.96 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Diabetic Footwear Market Size is Expected to Grow from USD 8.31 Billion in 2023 to USD 17.96 Billion by 2033, at a CAGR of 8.01% during the forecast period 2023-2033.
Browse key industry insights spread across 210 pages with 110 Market data tables and figures & charts from the report on the Global Diabetic Footwear Market Size, Share, and COVID-19 Impact Analysis, By Product (Slippers, Sandals, and Shoes), By Distribution Channel (Online and Offline), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The diabetic footwear market refers to the sector involved in the design, manufacture, and distribution of shoes specifically intended for individuals with diabetes. These footwear products are primarily designed to address the unique foot health needs of diabetic patients, including issues such as poor circulation, neuropathy, and increased susceptibility to foot infections and ulcers. Diabetic footwear aims to reduce the risk of injuries and improve overall comfort for individuals affected by diabetes, offering features such as cushioning, arch support, and a proper fit to enhance foot health. Moreover, the growth of the diabetic footwear market is driven by the increasing prevalence of diabetes globally, especially among aging populations. Rising awareness regarding the importance of proper foot care in managing diabetes has further contributed to the demand for specialized footwear. Additionally, advancements in product design and the growing availability of diabetic footwear through online platforms have expanded market access. However, the market faces challenges, such as the high cost of diabetic footwear, which may limit its accessibility for some patients. Furthermore, the availability of alternative treatment options and general footwear products that address similar needs may restrain market growth.
The shoes segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the product, the diabetic footwear market is classified into slippers, sandals, and shoes. Among these, the shoe segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. This growth can be attributed to the increasing demand for comprehensive foot protection, stability, and support that diabetic shoes provide. Diabetic shoes are specifically designed to address foot complications associated with diabetes, such as poor circulation and neuropathy.
The offline segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the distribution channel, the diabetic footwear market is divided into online and offline. Among these, the offline segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. This growth can be attributed to the widespread presence of retail outlets, including specialty stores, pharmacies, and medical supply stores, which provide consumers with the opportunity to physically try on diabetic footwear before making a purchase.
North America is estimated to hold the largest diabetic footwear market share over the forecast period.
North America is estimated to hold the largest diabetic footwear market share over the forecast period. Diabetes is on the rise in this region, thus there is an increasing demand for specific footwear that manages diabetes-related foot complications. Further, government incentives in the form of reimbursement programs offered by Medicare in the U.S. motivate patients to spend on specialty footwear that could avert major complications. These factors make North America the most important region within the diabetic footwear market due to its integral role in effectively treating health issues related to diabetes with specialized footwear.
Asia-Pacific is predicted to have the fastest CAGR growth in the diabetic footwear market over the forecast period. Rising awareness of diabetic foot care and rising diabetes rates in countries like China and India. In India, rapid urbanization has increased healthcare product purchases, including special diabetic footwear. The Diabetic Foot Education Program, for example, is a national program in India aimed at equipping the nation with knowledge regarding the prevention of diabetic foot complications and necessary foot-care education. The program seeks to improve healthcare quality for diabetic foot patients across India. Similarly, The Chinese government has initiated health promotion efforts in this age of urbanization, boosting demand for diabetic footwear.
Competitive Analysis
Major key players in the diabetic footwear market are Podartis Srl, Etonic Worldwide LLC, DARCO International Inc., Apex Foot Health Industries LLC, Dr. Comfort LLC, Advance Diabetic Solution, Drew Shoe Corporation, Aetrex Worldwide Inc., Dr. Zen Products, Inc., and Orthofeet Inc.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts global, regional, and country revenue from 2023 to 2033. Spherical Insights has segmented the diabetic footwear market based on the below-mentioned segments:
Global Diabetic Footwear Market, By Product
Global Diabetic Footwear Market, By Distribution Channel
Global Diabetic Footwear Market, By Regional Analysis
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa